A multinational, multi-centre, prospective, non-interventional, post-authorisation safety study in healthy donors (HDs) exposed to Nivestim (biosimilar filgrastim) for haematopoietic stem cell (HSC) mobilisation (NEST) First published 11/07/2016 Last updated 26/03/2020 EU PAS number:EUPAS14052 Study Ongoing